FibroGen

FibroGen, founded in 1993 is pharmaceutical company that to discovers, develops, and commercializes therapeutics involving fibrosis, or pathological scarring, addressing unmet needs in fibrotic disorders affecting the major organs, diabetes, surgical procedures, and fibroproliferative tumor progression and metastasis. The company is headquartered in San Francisco.